Press Releases

Featured Press Releases

BIO Applauds Farm Bill Progress, Calls for …

BIO commends the leaders and members of the House and Senate Agriculture Committees on their persistence and dedication toward passing a new farm bill this year. The farm bill is vital policy that benefits all Americans, including nutrition programs…

Learn more

BIO Statement Re Updated GREET Model to Measure…

The following statement may be attributed to Beth Ellikidis, BIO's Vice President for Agriculture & Environment: “Today’s release of an updated methodology to qualify crop-based sustainable aviation fuel (SAF) for federal tax credits is a…

Learn more

Admiral William McRaven to Keynote 2024 BIO…

Retired U.S. Navy (SEAL) Four-Star Admiral and the Former Chancellor of The University of Texas System, William McRaven, to Discuss Leadership, Global Events, and the National Security Importance of Biotechnology with BIO CEO, John Crowley …

Learn more

New USITC report shows "no credible evidence" supporting a TRIPs waiver expansion

October 17, 2023

The United States International Trade Commission (USITC) today released its “COVID-19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS Agreement Flexibilities” report. The report aims to analyze various issues and information gaps concerning…

Indiana Governor Eric Holcomb named BIO’s Governor of the Year

October 16, 2023

Today, the Biotechnology Innovation Organization (BIO) awarded Indiana Governor Eric Holcomb with its 2023 Governor of the Year Award. Throughout his tenure, Governor Holcomb has worked to support the promise of future bioscientific innovation and…

New BIO Working Groups Give Growing Ag & Environment Biotech Sector a Public Policy Voice

September 27, 2023

Updated regulatory working groups announced today by the Biotechnology Innovation Organization (BIO) reflect the rapidly increasing diversity and impact of BIO’s Agriculture & Environment membership and ensure that all member companies’…

ORPHAN Cures Act a "welcome and bipartisan fix" to the IRA's negative impact on drug development

September 18, 2023

Representatives John Joyce, M.D. (R-PA) and Wiley Nickel (D-NC) today introduced the Optimizing Research Progress Hope And New Cures (ORPHAN Cures Act). BIO President and CEO, Rachel King, made the following remarks: "This legislation is a welcome…

BIO Honors Biotech Leaders for Breakthroughs in Ag & Environment Biotech

September 12, 2023

The Biotechnology Innovation Organization has honored two biotechnology leaders who are driving cutting-edge breakthroughs in agricultural, environmental and industrial biotechnology. Dr. Pam Marrone, Co-founder and Executive Chair of Invasive…

BIO Applauds FTC Settlement Decision

September 1, 2023

Yesterday the Federal Trade Commission (FTC) announced the decision to settle its Amgen-Horizon merger challenge. The settlement will give the Commission the relief it needs to protect competition, while allowing rare disease patients to enjoy the…

BIO Podcast 2023 Fall Season Launch

August 30, 2023

New Season of I am BIO Podcast Covers Birds, Bees, and Bugs Fall 2023 season explores biotech solutions for wildlife conservation, bee health, drug-resistant bugs, and more Washington – (Aug. 30, 2023) – Save the date―the Biotechnology Innovation…

BIO Statement on CMS Announcement of First 10 Drugs Subject to Price Controls Under IRA

August 29, 2023

The Biden Administration today unveiled the first 10 prescription drugs that will be subject to price controls under the Inflation Reduction Act (IRA). Rachel King, BIO interim President and CEO, made the following statement: The Medicare price…

BIO FILES AMICUS BRIEF CHALLENGING FTC’S OVERREACH ON MERGER ENFORCEMENT THAT THREATENS DRUG DEVELOPMENT INNOVATION

August 24, 2023

BIO released the following statement from John Delacourt, BIO’s Deputy General Counsel, on BIO’s amicus brief opposing the Federal Trade Commission (FTC) lawsuit to block the acquisition of Horizon by Amgen: “The FTC’s current overreach in…

Dispute Panel 'Important Next Step' to Return to Science-Based Trade with Mexico

August 17, 2023

The following statement may be attributed to Nancy Travis, vice president of international affairs, BIO. “The Biotechnology Innovation Organization supports today’s action by the Office of the U.S. Trade Representative to request formation of a…

Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy.